Affinia Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
WALTHAM, Mass., May 28, 2024 /PRNewswire/ -- Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and…
